Outcomes4Me, a Boston, MA-based developer of a direct-to-patient, AI-driven platform, raised $21M in funding.
The spherical was led by Salica Investments, with participation from present traders Labcorp Enterprise Fund, Forecast Labs, Northpond Ventures, Sierra Ventures, Asset Administration Ventures, IRA Capital, and Merstal LTD.
The corporate intends to make use of the funds to:
- Speed up its market penetration throughout a broader vary of most cancers varieties, geographies, and international markets.
- Leverage its proprietary datasets and increase its AI capabilities.
- Enhance and scale its collaborations with well being methods and life sciences firms globally.
- Scale its income streams by way of new partnerships, worldwide growth, and progressive enterprise fashions.
- Drive outcomes-based proof era and real-world knowledge insights for improved therapy and care.
Led by CEO and Founder Maya R. Mentioned, Outcomes4Me is a supplier of an end-to-end, AI-driven affected person empowerment platform that helps sufferers with most cancers take a proactive method to their care from analysis all through each stage of life and care. It integrates scientific pointers, genomics, trial matching, and symptom monitoring to assist sufferers navigate by way of a most cancers analysis with confidence and readability.
The increase introduced the entire capital raised to this point to $38M.
FinSMEs
30/05/2025
